JPM vs MXF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MXF exhibits a stable financial profile with a Piotroski F-Score of 5/9 and is trading at a massive discount to its Graham Number ($51.05) and Intrinsic Value ($36.82). The company's valuation is exceptionally attractive, evidenced by a P/E ratio of 3.96 and a Price/Book ratio of 0.95, significantly underperforming sector averages. Strong profitability is highlighted by a 26.31% ROE and a sustainable 6.71% dividend yield with a low payout ratio. Despite a bearish short-term technical trend and negligible insider selling, the fundamental value proposition is compelling.
Compare Another Pair
Related Comparisons
JPM vs MXF: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and The Mexico Fund, Inc. (MXF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.